Report Puts Forward Four Steps to Accelerate Drug Access in Canada

November 14, 2022

A recent report from the Conference Board of Canada posits four steps to speed up access to cancer therapeutics in Canada. First, they recommend changing the current health technology assessment (HTA) practices to provide additional pathways that will allow patients to access drugs while payers, pharma, and regulatory bodies work out reimbursement strategies.

The next step, according to Medical Innovation Report, is to, “Change the way breakthrough therapies are funded to facilitate value-based care and risk-sharing agreements. Other countries have risk-sharing models such as managed entry and outcome-based agreements to deal with the uncertainty associated with the long-term value of breakthrough therapies in achieving patient outcomes.”

To read more, click here.

(Source: The Globe and Mail, November 14th, 2022)

Share This Story!